Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pediatric NexoBrid versus standard of care for thermal burns
2014-003066-24Phase 3Completed
- Sponsor
- MediWound
- Start
- Oct 2014
- Modality
- Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in thermal injury comparing NexoBrid with Standard of care (2 arms). Primary endpoint: Earlier eschar removal. Started Oct 2014; status: completed.
02
Drugs
bromelain
03
Conditions
thermal injury
Beyond the preview
Go deeper on 2014-003066-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-003066-24.